NCT01524939View on ClinicalTrials.gov

"Study of Combined Therapy of Aspirin and IVIG-SN in Kawasaki Disease"

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Kawasaki Disease
Interventions
DRUG

immunoglobulin G

Intravenously administer a single dose of the product (2g/kg) for at least 12 hours

Trial Locations (7)

220-701

Wonju christian Hospital, Wŏnju

Unknown

Gachon University Gil Hospital, Incheon

Asan Medical center, Seoul

Kyung Hee university at Gangdong, Seoul

Kyung Hee university medical center, Seoul

Samsung Medical Center, Seoul

Seoul ST. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY

NCT01524939 - "Study of Combined Therapy of Aspirin and IVIG-SN in Kawasaki Disease" | Biotech Hunter | Biotech Hunter